Breaking away: high fracture rates may merit a new trial of adjuvant endocrine therapy in Scandinavian breast cancer patients.
作者:
主题词
抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);芳香酶抑制剂(Aromatase Inhibitors);骨密度保护剂(Bone Density Conservation Agents);乳腺肿瘤(Breast Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);共病现象(Comorbidity);无病生存(Disease-Free Survival);女(雌)性(Female);骨折(Fractures, Bone);人类(Humans);随机对照试验(主题)(Randomized Controlled Trials as Topic);他莫昔芬(Tamoxifen)
DOI
10.3109/0284186X.2012.742963
PMID
23193962
发布时间
2014-11-20
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文